Transfusion medicine for the pediatrician

被引:3
作者
Quirolo, KC
机构
[1] Univ Calif San Francisco, Dept Clin Lab Med, Moffitt Long Hosp, San Francisco, CA 94143 USA
[2] Childrens Hosp & Res Ctr, Dept Hematol, Oakland, CA 94609 USA
关键词
D O I
10.1016/S0031-3955(02)00090-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Over the past few years, major changes in transfusion medicine have improved the safety of the supply of blood, particularly in the areas of infectious disease testing and processing. Since about 1990, blood banking has been regulated as a manufacturing process similar to the manufacturing of pharmaceuticals. This has led to more uniform blood products with more predictable outcomes. Recommendations have been made for universal leukoreduction, more uniform collection of blood products, pathogen inactivation of blood products, and a quest for a "zero risk" blood product. These new practices and regulations have made blood banking more complex, resulting in the acquisition of many local blood banks by the two major blood suppliers: Blood Systems Inc. and the American Red Cross.
引用
收藏
页码:1211 / +
页数:29
相关论文
共 83 条
  • [41] MARROW JF, 1991, JAMA-J AM MED ASSOC, V266, P555
  • [42] Evaluation of donor arm disinfection techniques
    McDonald, CP
    Lowe, P
    Roy, A
    Robbins, S
    Hartley, S
    Harrison, JF
    Slopecki, A
    Verlander, N
    Barbara, JAJ
    [J]. VOX SANGUINIS, 2001, 80 (03) : 135 - 141
  • [43] Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States
    McQuiston, JH
    Childs, JE
    Chamberland, ME
    Tabor, E
    [J]. TRANSFUSION, 2000, 40 (03) : 274 - 284
  • [44] MICHELL KM, 1999, TRANSFUS MED REV, V13, P132
  • [45] HTLV-I UVEITIS - A DISTINCT CLINICAL ENTITY CAUSED BY HTLV-I
    MOCHIZUKI, M
    WATANABE, T
    YAMAGUCHI, K
    TAKATSUKI, K
    YOSHIMURA, K
    SHIRAO, M
    NAKASHIMA, S
    MORI, S
    ARAKI, S
    MIYATA, N
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (03): : 236 - 239
  • [46] PREVENTION OF TRANSFUSION-ASSOCIATED CHAGAS-DISEASE - EFFICACY OF WHITE CELL-REDUCTION FILTERS IN REMOVING TRYPANOSOMA-CRUZI FROM INFECTED BLOOD
    MORAESSOUZA, H
    BORDIN, JO
    BARDOSSY, L
    MACPHERSON, DW
    BLAJCHMAN, MA
    [J]. TRANSFUSION, 1995, 35 (09) : 723 - 726
  • [47] Securing viral safety for plasma derivatives
    Morgenthaler, JJ
    [J]. TRANSFUSION MEDICINE REVIEWS, 2001, 15 (03) : 224 - 233
  • [48] Transfusion-transmitted malaria in the United States from 1963 through 1999
    Mungai, M
    Tegtmeier, G
    Chamberland, M
    Parise, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (26) : 1973 - 1978
  • [49] Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors
    Murphy, EL
    Glynn, SA
    Fridey, J
    Sacher, RA
    Smith, JW
    Wright, DJ
    Newman, B
    Gibble, JW
    Ameti, DI
    Nass, CC
    Schreiber, GB
    Nemo, GJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) : 1468 - 1475
  • [50] Single-donor platelets reduce the risk of septic platelet transfusion reactions
    Ness, P
    Braine, H
    King, K
    Barrasso, C
    Kickler, T
    Fuller, A
    Blades, N
    [J]. TRANSFUSION, 2001, 41 (07) : 857 - 861